Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease intestinal disease
Comorbidity C0022104|irritable bowel syndrome
Sentences 23
PubMedID- 26396720 Background irritable bowel syndrome (ibs) is one of the common gastrointestinal disorders with unknown etiology.
PubMedID- 23668698 Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity.
PubMedID- 21292684 Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease.
PubMedID- 25083054 irritable bowel syndrome (ibs) is one of the most common gastrointestinal disorders causing patients to seek medical treatment.
PubMedID- 23066886 Background: irritable bowel syndrome (ibs), one of the most common gastrointestinal disorders, markedly impairing patients' quality of life.
PubMedID- 24627583 irritable bowel syndrome (ibs) is one of the most common gastrointestinal disorders, characterized by abdominal pain, bloating, and changes in bowel habits.
PubMedID- 26426460 irritable bowel syndrome in patients with quiescent inflammatory bowel disease.
PubMedID- 24903042 irritable bowel syndrome (ibs) is one of the most common gastrointestinal diseases.
PubMedID- 23855395 Commentary: symptoms of irritable bowel syndrome in patients with inflammatory bowel disease--organic disease or diseased organ.
PubMedID- 26109796 irritable bowel syndrome (ibs) is one of the most common gastrointestinal disorders, having a prevalence of 12%-30% in the general population.
PubMedID- 25732091 Introduction: irritable bowel syndrome (ibs) is one of the most common gastrointestinal disorders with a 9 - 23% prevalence estimated in the general population.
PubMedID- 24417262 The nature and clinical implications of irritable bowel syndrome (ibs)-type symptoms in patients with inflammatory bowel disease (ibd) who are in apparent remission have generated considerable debate.
PubMedID- 26088265 irritable bowel syndrome is one of the most common gastrointestinal disorders in developed nations.
PubMedID- 23864772 This is particularly true, for instance, for irritable bowel syndrome, the prototype entity of "functional" gastrointestinal disorders, where low-grade inflammation of both mucosa and myenteric plexus has been repeatedly demonstrated.
PubMedID- 25580205 Background: faecal calprotectin (fc), a cytosolic protein released by neutrophils (s100 family) in response to inflammation, is a simple, non-invasive test that can be used to differentiate irritable bowel syndrome (ibs) with inflammatory bowel disease (ibd), where there can be considerable symptom overlap.
PubMedID- 22864805 This review will focus on the role of campylobacter infection as a risk factor for the development of chronic gastrointestinal sequelae, such as functional gastrointestinal disorders, with which irritable bowel syndrome has been most frequently associated, inflammatory bowel disease, and celiac disease.
PubMedID- 24829694 Background: irritable bowel syndrome is one of the most common gastrointestinal disorderscharacterized by chronic abdominal pain, altered bowel habits or changesin stool consistency.
PubMedID- 20389294 irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation.
PubMedID- 25083057 irritable bowel syndrome (ibs) is one of the most common gastrointestinal disorders in western countries.
PubMedID- 23130604 irritable bowel syndrome (ibs) is one of the most common gastrointestinal disorders and it is characterized by episodes of abdominal pain and altered bowel functions.
PubMedID- 21374060 Compared with controls, patients with suspected irritable bowel syndrome had higher prevalence of noninflammatory bowel disease and noninfectious colitis and terminal ileitis, however, had lower prevalence of diverticular disease, adenomatous polyps, and non-adenomatous polyps (all p < 0.001).
PubMedID- 25142170 More recently, studies in humans provide evidence that serum-derived bovine immunoglobulin/protein isolate is safe and improves nutritional status and gi symptoms in patients with enteropathy associated with irritable bowel syndrome or infection with the human immunodeficiency virus.
PubMedID- 25855880 This has been used to distinguish patients exhibiting symptoms of irritable bowel syndrome from patients with inflammatory bowel disease, with a measure of success greater than with currently used techniques.

Page: 1